Maintenance notice in CEST time zone (1:00 - 3:30 AM May 17, 2026): Our website is scheduled for maintenance. The website will be available, but some functions may experience errors. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 112052-11-6 | Product Number: T4367
(S)-Tetrahydrofuran-3-yl 4-Methylbenzenesulfonate
×
Purity: >98.0%(HPLC)
Synonyms:
- (3S)-Tetrahydro-3-furanyl 4-Methylbenzenesulfonate
- (S)-Toluene-4-sulfonic Acid Tetrahydrofuran-3-yl Ester
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
€135.00
|
Contact Us | 16 |
|
|
| 25G |
€430.00
|
Contact Us | 16 |
|
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | T4367 |
Purity / Analysis Method 
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__1H__1__4O__4S = 242.29 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Moisture Sensitive,Heat Sensitive |
| CAS RN | 112052-11-6 |
| Reaxys Registry Number | 4458174 |
| MDL Number | MFCD08704351 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 37.0 to 41.0 °C |
| Specific rotation | -4.0 to -6.0 deg(C=2, MeOH) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 39 °C |
GHS
Related Laws:
Transport Information:
| HS Number | 2932190090 |
Application
A Chiral Auxiliary Reagent for the Synthesis of Bioactive Compounds Containing the Chiral Tetrahydrofuran-3-yl Group
This product has been used to synthesize bioactive compounds containing the chiral tetrahydrofuran-3-yl group. Examples include G2019S, a leucine-rich repeat kinase 2 (LRRK2) inhibitor with potential utility in treating Parkinson's disease.
References
- Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate
- BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition Free
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.